LN-4305

N/A

Report date: 2026/05/11 20:01:57

Base Information

Drug NameLN-4305
Drug Alias NameLN-4305
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Antibody conjugate > Antibody drug conjugate (ADC)Biologics > Protein drugs > Immunoglobulin > Antibody > Antibody conjugate > Antibody drug conjugate (ADC) > Linker > Cleavable linker > β-Glucuronic acid linkerBiologics > Protein drugs > Immunoglobulin > Antibody > Antibody conjugate > Antibody drug conjugate (ADC) > Payload > Exatecan payload
Mechanisms of ActionAnti-NECTIN4DNA topoisomerase I inhibitors
TargetsNectin-4DNA topoisomerase I
Therapy Area/IndicationsSolid tumours
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesIsraelSouth Korea
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesLigaChem Biosciences IncNectin Therapeutics LtdAntibodyChem Biosciences Inc
China Registration ClassN/A

Develop Information

Active CompaniesLigaChem Biosciences IncAntibodyChem Biosciences IncNectin Therapeutics Ltd
Inactive CompaniesN/A
Active IndicationsSolid tumours
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A